Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

VERV Stock Forecast, Price Targets, Chart, Dividends & Analysis

Verve Therapeutics Inc.

Sector: Professional, Scientific, and Technical Services   

Industry: Research and Development in Biotechnology

6.16
 
USD
  
-0.16
  
(-2.53%)
Previous close: 6.32  Open: 5.99  Bid: 5.76  Ask: 6.15
52 week range    
2.87   
   9.31
Mkt Cap: 569 M  Avg Vol (90 Days): 3,457,722
Last updated: Monday 16th June 2025

Stock Rankings

52
MarketXLS Rank
60
Value
63
Technical
34
Quality
How are these ranks calculated?
Metrics

Growth

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

VERV Income Statement

Annual
Invalid dateDec-21Dec-22Dec-23Dec-24
Basic EPS from continuing operations-4.48-2.91-3.12-2.35
Basic EPS total-4.48-2.91-3.12-2.35
Basic weighted shares outstanding27 M54 M64 M85 M
Depreciation2 M3 M5 M7 M
DepreciationAndAmortization2 M3 M5 M7 M
Diluted EPS total-4.48-2.91-3.12-2.35
Diluted normalized net income/share-2.91-3.12-2.35
Diluted weighted shares outstanding54 M64 M85 M
GeneralAndAdministrativeExpense19 M38 M50 M57 M
Gross operating profit12 M
Income before tax-120 M-157 M-200 M-198 M
Income taxes53000.0275000.0349000.0
MiscOtherSpecialCharges-33 M8 M23 M29 M
Net income from total operations-120 M-157 M-200 M-199 M
NetIncomeCommonStockholders-120 M-157 M-200 M-199 M
NetIncomeContinuousOperations-120 M-157 M-200 M-199 M
NetNonOperatingInterestIncomeExpense-7 M-23 M
Normalized income-196 M
Operating income-87 M-166 M-223 M-229 M
Operating income before depreciation (EBITDA)-117 M-163 M-209 M-204 M
OperatingExpense87 M168 M235 M261 M
Other income net33 M1 M-23 M-29 M
OtherGandA19 M38 M50 M57 M
OtherOperatingExpenses5 M8 M18 M20 M
Research & development expense68 M130 M185 M204 M
ResearchExpense68 M130 M185 M204 M
SalariesAndWages-2 M35 M43 M
Selling Gen & administrative expense19 M38 M50 M57 M
Total Income available for interest expense (EBIT)-120 M-166 M-200 M-198 M
Total common shares outstanding49 M62 M84 M
Total net income-120 M-157 M-200 M-199 M
Total ordinary shares89 M89 M89 M89 M
Total revenues2 M12 M32 M
TotalExpenses87 M168 M235 M261 M
TotalRevenue2 M12 M32 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader